TICKERNERD
Menu
NRCNRCHealthcare · Health Information Services

NRC Stock Forecast: NRC Health Price Predictions for 2026-2027

Last close, 21 Aug 2026
$22
+1.70% on the day

The 1 Wall Street analysts covering NRC Health hold a median 12-month price target of $26 — +17.2% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 87 of 100 as at 21 Aug 2026 — inside the top quartile. Here, the model and the Street point the same way.

Market cap
$490.4M
Ticker Nerd rank
87 / 100
Median analyst target
$26
Analysts covering
1
Total return, dividends reinvested
1W
+4.7%
1M
+3.3%
YTD
+20.6%
1Y
+59.3%
From 52W high
−2.5%
From 52W low
+100.5%
$11
$23
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

NRC stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores NRC Health on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 21 Aug 2026
87 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Momentum
96
Accruals
91
Quality
78
Volatility
74
Value
59
Revisions
59
Issuance
57
Size
54
Growth
36

Momentum (96): The shares have been drifting up relative to others.

Growth (36): Sales and profits are flat, shrinking, or growing more slowly than they were.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

NRC stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on NRC, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$10$15$20$25Oct 25Jan 26Apr 26Jul 26NRCHigh $26Median $26Low $26

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

What Wall Street says1 analysts
1 Buy0 Hold0 Sell
Low $26Median $26High $26

The green dot is the last close — the median target sits +17.2% from it.

Recent analyst actionsNewest first
DateFirmActionRatingTarget
29 July 2026CitizensMaintainsMarket Outperform$23 → $26
22 June 2026CitizensInitiatesMarket Outperform$23
22 June 2026CitizensInitiatesMarket Outperform—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. NRC appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Estimates

NRC analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
Analysts raising
0
Analysts cutting
1
Fundamentals

NRC Health (NRC) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
91.3×

Cheaper than 8% of US stocks

Price / sales
3.5×

Cheaper than 37% of US stocks

Price / book
74.0×

Cheaper than 2% of US stocks

EV / EBITDA
21.4×

Cheaper than 15% of US stocks

Growth & margins
Revenue growth (YoY)
4.0%

Higher than 36% of US stocks

Earnings growth (YoY)
−44.3%

Higher than 11% of US stocks

Gross margin
61.7%

Higher than 75% of US stocks

Operating margin
−0.2%

Higher than 32% of US stocks

Net margin
4.2%

Higher than 58% of US stocks

Returns & dividend
Return on equity
42.0%

Higher than 92% of US stocks

Return on assets
8.1%

Higher than 88% of US stocks

Dividend yield
2.9%

Higher than 63% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

NRC vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelHealth Information Services
CompanyMarket capTKN rank
NRCNRC Health$490.4M
87
EVHEvolent Health, Inc.$529.2M
63
CARLCarlsmed, Inc.$436.3M
22
WEAVWeave Communications, Inc.$583.2M
80
CTEVClaritev Corp.$614.0M
64
SLPSimulations Plus, Inc.$372.1M
90
SOPHSOPHiA GENETICS SA$712.0M
50

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own NRC Health — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest NRC news & analysis

NRC Down 8% Despite Q2 Earnings Rising Y/Y on TRCV Growth

Zacks Investment Research · 3 Aug 2026neutral

NRC Health's shares fell 8% even as its Q2 earnings per share rose year over year, driven by higher recurring contract value and strong Governance Institute bookings, partly offset by elevated operating expenses.

Why it matters — NRC watchers would see this as a mixed signal: the underlying business grew on recurring revenue and bookings strength, but the stock declined and rising operating expenses weighed on results.

NRC Health (NRC) Q2 2026 Earnings Call Transcript

Seeking Alpha · 29 July 2026neutral

NRC Health held its Q2 2026 earnings call, with the transcript published by Seeking Alpha. The call covered the company's financial results and operational performance for the quarter.

Why it matters — The earnings call transcript provides NRC watchers with management's perspective on the company's recent financial performance and strategic outlook.

National Research Q2 Earnings Call Highlights

MarketBeat · 28 July 2026positive

National Research (NRC Health) reported second-quarter results with 11% year-over-year growth in total recurring contract value, while management noted that investments in implementation, customer success, and product development supported a large customer deployment and future growth efforts.

Why it matters — The recurring contract value growth and management's investment commentary signal how NRC Health is managing customer deployments and positioning for future expansion.

NRC Health Announces Second Quarter 2026 Results

Business Wire · 28 July 2026positive

NRC Health announced its second quarter 2026 results, reporting double-digit TRCV growth year-over-year, strong execution in go-to-market and solutions delivery, and the strongest bookings performance for The Governance Institute in seven years.

Why it matters — The results highlight operational momentum across key growth areas including revenue, product innovation, and bookings, which are central to NRC Health's performance outlook.

FAQ

Frequently asked questions about NRC stock

What is the NRC stock price forecast for 2026-2027?

The 1 Wall Street analysts covering NRC Health have a median 12-month price target of $26, with estimates ranging from $26 to $26. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is NRC stock a buy right now?

Of the 1 analysts covering NRC Health, 1 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks NRC Health 87 out of 100 across roughly 4,600 US stocks as at 21 Aug 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank NRC?

As at 21 Aug 2026, NRC Health ranks 87 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Momentum (96 of 100).

Will NRC stock go up?

No one can know that. What the data says: the median 12-month target from 1 analysts implies +17.2% from the last close, and Ticker Nerd's factor model ranks NRC Health 87 out of 100 as at 21 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the NRC stock forecast for 2030?

No analyst covering NRC Health publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for NRC are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $26 to $26 over the next 12 months.

How has NRC stock performed over the past year?

NRC Health returned +59.3% over the 12 months to 21 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does NRC Health do?

National Research Corporation is a prominent organization specializing in healthcare data analytics and insights. Its primary function is to provide comprehensive survey-based analytics and tools that support healthcare systems, medical practices, and businesses in understanding patient experiences and improving care quality.

What is the latest news on NRC?

The most recent item we track (Zacks Investment Research, 3 Aug 2026): "NRC Down 8% Despite Q2 Earnings Rising Y/Y on TRCV Growth". NRC Health's shares fell 8% even as its Q2 earnings per share rose year over year, driven by higher recurring contract value and strong Governance Institute bookings, partly offset by elevated operating expenses.

Company

About NRC Health.

National Research Corporation is a prominent organization specializing in healthcare data analytics and insights. Its primary function is to provide comprehensive survey-based analytics and tools that support healthcare systems, medical practices, and businesses in understanding patient experiences and improving care quality. National Research Corporation plays a vital role in the healthcare industry by delivering actionable intelligence that influences how healthcare providers engage with patients and foster improvement across various healthcare delivery areas. The company's services extend across numerous healthcare sectors, including hospitals, health plans, and post-acute care services. National Research Corporation is integral to refining strategies for patient engagement, clinical outcomes, and operational efficiency. Its reputation is built on empowering healthcare organizations with reliable data and insights, aiding these institutions in navigating the complexities of patient-centered care amidst evolving industry standards and regulations. Through its diverse range of products, the corporation remains essential to the transformation and improvement of patient care and satisfaction within the healthcare market.

CEO Mr. Trent S. Green · 357 employees · United States · https://www.nrchealth.com